Evidence map›Paper›PMID 34445034›Full record

ArticleNutrients2021

A New Disease Concept in the Age of Processed Foods-Phosphorus-Burden Disease; including CKD-MBD Concrete Analysis and the Way to Solution.

Keizo Nishime, Noriko Sugiyama, Koichi Okada

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Keizo NishimeDepartment of Nephrology, Rakuwakai Nijo Ekimae Clinic, 3 Higashitoganoo-cho, Nishinokyo, Nakagyo Ward, Kyoto City 604-8414, Japan.ORCID 0000-0002-0628-322X
Noriko SugiyamaDepartment of Medical Information, Rakuwakai Headquarters, 51-7 Otowa Hachinotubo, Yamashina Ward, Kyoto City 607-8064, Japan.
Koichi OkadaDepartment of Nephrology and Dialysis Surgery, Rakuwakai Otowa Memorial Hospital, 29-1 Otowachinjyucho, Yamashina Ward, Kyoto City 607-8116, Japan.
Rakuwakai Otowa Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2012, the Japanese Society for Dialysis Therapy (JSDT) established the order of correction of P, corrected Ca (cCa), and whole PTH (w-PTH) in the treatment of Chronic Kidney Disease-Metabolic Bone Disorder (CKD-MBD) as P-first. However, there is no report that analyzes whether this rule is in line with reality and what the adequate rate of P is. Therefore, we analyzed the test values of our 48 patients during the year of 2019 and examined the validity of the results. The results showed that the adequate range rates were 70.8% for P, 100% for cCa, and 89.6% for w-PTH. This result is better than the JSDT Web-based Analysis of Dialysis Data Archives (WADDA) P adequacy rate of 66.2%. Although the guideline is P-first, it is often the case that we cannot reach the adequate level; therefore, healthcare professionals and patients often blame each other. We believe that this is due to the mismatch between the modern era of processed foods covered with P additives and treatment methods (P intake restriction and P-binders). The development of processed foods with P additives has brought light and darkness to mankind. The light side is freedom from starvation, and the dark side is a new condition caused by P burden: P burden disease including CKD-MBD.

Indexed as

Food HandlingBiomarkersCalcimimetic AgentsCalciumChelating AgentsChronic Kidney Disease-Mineral and Bone DisorderFibroblast Growth Factor-23Food AdditivesHumansParathyroid HormonePhosphorus CompoundsPhosphorus, DietaryPrognosisRenal DialysisRisk AssessmentRisk FactorsBiomarkersCalcimimetic AgentsCalciumChelating AgentsFGF23 protein, humanFibroblast Growth Factor-23Food AdditivesParathyroid HormonePhosphorus CompoundsPhosphorus, DietaryPTH protein, humanCKD–MBDfibroblast growth factor 23(FGF23)phosphorus absorption inhibitorphosphorus additivesphosphorus bindersphosphorus burdenprocessed foodssodium-hydrogen exchanger 3 inhibitor (NaHE3 Inhibitor)

Identifiers

PMID34445034
PMCPMC8399778
OpenAlexW3194166258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.